Professor and Chair of the Division of Imaging Sciences of the Department of Medical Imaging at The Western University. Founder and past Director of the Imaging Research Laboratories (IRL) at the Robarts Research Institute
Fenster is a Scientist at the Robarts Research Institute, founding and founder and past Director of the Imaging Research Laboratories (IRL) at the Robarts Research Institute. He is a Professor and Chair of the Division of Imaging Sciences of the Department of Medical Imaging at The Western University. In addition, he is the founder and past Director of the interdisciplinary graduate Program in Biomedical Engineering and past Director for the Biomedical Imaging Research Centre at The Western University. This Centre integrates the strengths in imaging research across London’s Institutions, which combined, makes the London medical imaging research community one of the largest in North America with over 350 staff and students and $100M in research equipment. In 2007 he became the Director of the Imaging Program at the Ontario Institute for Cancer Research (OICR). In 2010 he became the Founder, Acting CEO and Centre Director of the Centre for Imaging Technology Commercialization (CIMTEC) – a federally funded Centre of Excellence in Commercialization and Research. Currently, he is its CEO.
Fenster’s laboratory has been pioneering the development of 3D ultrasound imaging and image-guided interventional systems in radiology, oncology, urology, neonatology and vascular imaging with some successfully translated into clinical use and to companies (13 licenses to companies). Most recently, his lab has developed 3DUS image-guided interventional systems for prostate biopsy and brachytherapy, breast brachytherapy and MR-guided focal laser thermal prostate ablation in the bore of the MR magnet, and 3DUS focal liver tumor ablation system. Successfully translated applications include: 3D transrectal US/MR prostate biopsy, cryosurgery, brachytherapy and breast biopsy; MR-guided focal prostate laser ablation; 3DUS applications for carotid imaging for sensitive monitoring of carotid atherosclerosis and quantification of disease burden; and 3DUS imaging of preterm infants’ brains to assess post hemorrhagic ventricle dilation.